Literature DB >> 4200649

The enhancement of macrophage bacteriostasis by products of activated lymphocytes.

R E Fowles, I M Fajardo, J L Leibowitch, J R David.   

Abstract

It was reported previously that the incubation of normal guinea pig macrophages with partially purified products of activated lymphocytes resulted in altered macrophage function including increased cell adherence to culture vessels, spreading, phagocytosis, and glucose carbon-1 oxidation. Studies reported here demonstrate that such macrophages also exhibit enhanced bacteriostasis. Lymphocytes were stimulated with concanavalin A, the culture supernatant was chromatographed over Sephadex G-100 and the fraction of mol wt 25,000-55,000, rich in lymphocyte mediators, was cultured with normal guinea pig macrophages for 1-3 days. Macrophages incubated with fractions from unstimulated lymphocyte cultures served as controls. The resulting macrophage monolayers were infected with Listeria monocytogenes. Macrophages incubated with mediator-rich fractions exhibited 2- to 10-fold enhanced bacteriostasis compared to controls. Further studies indicate that this enhancement was attributable to intrinsic changes in the macrophages and not simply a consequence of the number of macrophages on the monolayers. The studies support the concept that macrophage bacteriostasis can be enhanced by lymphocyte mediators. However, macrophages, which have been preincubated directly with sensitive lymphocytes and antigen exhibit even greater bacteriostasis and sometimes bactericidal capacity, suggesting that either a labile lymphocyte factor or direct lymphocyte macrophage interaction may also be involved in bactericidal activity.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4200649      PMCID: PMC2180559          DOI: 10.1084/jem.138.4.952

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Passive transfer of resistance to tuberculosis through use of monocytes.

Authors:  J L SEVER
Journal:  Proc Soc Exp Biol Med       Date:  1960-02

2.  Enhancement of macrophage bactericidal capacity by antigenically stimulated immune lymphocytes.

Authors:  H B Simon; J N Sheagren
Journal:  Cell Immunol       Date:  1972-06       Impact factor: 4.868

3.  Lymphocyte-mediated modification of blood-derived macrophage function in vitro; inhibition of growth of intracellular mycobacteria with lymphokines.

Authors:  T Godal; R J Rees; J O Lamvik
Journal:  Clin Exp Immunol       Date:  1971-04       Impact factor: 4.330

4.  In vitro induction of nonspecific resistance in macrophages by specifically sensitized lymphocytes.

Authors:  J L Krahenbuhl; J S Remington
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

5.  Characterization of migration inhibitory factor (MIF) from guinea pig lymphocytes stimulated with concanavalin A.

Authors:  H G Remold; R A David; J R David
Journal:  J Immunol       Date:  1972-09       Impact factor: 5.422

6.  Demonstration in tissue culture of lymphocyte-mediated immunity to tuberculosis.

Authors:  R J Patterson; G P Youmans
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

7.  Alterations of macrophage functions by mediators from lymphocytes.

Authors:  C F Nathan; M L Karnovsky; J R David
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

8.  Cellular immunity in vitro. I. Immunologically mediated enhancement of macrophage bactericidal capacity.

Authors:  H B Simon; J N Sheagren
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

9.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

10.  THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1964-07-01       Impact factor: 14.307

View more
  77 in total

1.  Host defenses in experimental scrub typhus: role of normal and activated macrophages.

Authors:  C A Nacy; J V Osterman
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

2.  Antibacterial product of peritoneal exudate cell cultures from guinea pigs infected with mycobacteria, listeriae, and rickettsiae.

Authors:  S D Sharma; G Middlebrook
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

3.  Lymphokine-induced production and release of lysosomal enzymes by macrophages.

Authors:  R M Pantalone; R C Page
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

4.  Different effects of phytohemagglutinin-activated lymphocytes and their culture supernatants on macrophage function.

Authors:  M Ando; M Suga; K Shima; M Sugimoto; S Higuchi
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

5.  A journey in science: promise, purpose, privilege.

Authors:  Carl Nathan
Journal:  Mol Med       Date:  2013-10-03       Impact factor: 6.354

6.  Dichotomy between macrophage activation and degree of protection against Listeria monocytogenes and Toxoplasma gondii in mice stimulated with Corynebacterium parvum.

Authors:  J E Swartzberg; J L Krahenbuhl; J S Remington
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

7.  Effect of glucocorticosteroids on the phagocytosis and intracellular killing by peritoneal macrophages.

Authors:  T L Zwet; J Thompson; R Furth
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

8.  Interaction between Coxiella burnetii and guinea pig peritoneal macrophages.

Authors:  R A Kishimoto; J S Walker
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

9.  Cell-mediated immune phenomena induced by lymphokines from splenic lymphocytes of mice with chronic staphylococcal infection.

Authors:  R E Baughin; P F Bonventre
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

10.  Bronchopulmonary cellular response to aluminum and zirconium salts.

Authors:  R P Stankus; M R Schuyler; R A D'Amato; J E Salvaggio
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.